How COVID-19 Could Impact Cannabis Stocks

The cannabis sector has evolved substantially since I began following it 7 years ago, but the COVID-19 crisis has made it as challenging as ever to navigate. I created...
- April 5th, 2020 at 12:08 pm

The Downside of Narrowly Focused Cannabis Operations

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
- April 5th, 2020 at 10:55 am

Acreage Holdings Retrenches Across Multiple Markets

Acreage Announces Operational Updates, Executive Resignation, Suspension of Guidance and Termination of Proposed Deep Roots Acquisition NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or...
- April 3rd, 2020 at 8:33 am

Green Growth Brands Puts Its CBD Business Into Receivership

Green Growth Brands Announces Conclusion of Strategic Review Process, Consent to Receivership Appointment for CBD Business, and Continuation of Cannabis Business in Florida, Massachusetts, and Nevada COLUMBUS, OH, April 3,...
- April 3rd, 2020 at 7:24 am

The Global Cannabis Stock Slide Accelerated in March

Already down sharply through February, the Global Cannabis Stock Index extended its losses with a 24.9% decline during March, ending at 23.58 despite a bounce from record lows mid-month: The index,...
- April 1st, 2020 at 11:45 am

Tilray to Allow Early Release of 11 Million Locked-Up Shares

Tilray, Inc. Releases 11 Million Shares From Lock-Up Agreement NANAIMO, British Columbia, March 31, 2020-(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: TLRY) (“Tilray”), a global pioneer in cannabis production, research, cultivation and...
- March 31st, 2020 at 8:37 am

Cronos Group Q4 Revenue Sinks to $7.3 Million

Cronos Group Reports 2019 Fourth Quarter and Full-Year Results Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product...
- March 30th, 2020 at 4:34 pm

HEXO Corp Takes $266 Million Impairment Charges

HEXO Corp reports second quarter fiscal 2020 financial results Key Operating Highlights Net Revenue increased 17% to $17.0M from $14.5M in Q1 Adult-use grams and gram equivalents sold increased...
- March 30th, 2020 at 8:07 am

MediPharm Labs Generates $32 Million Revenue in Q4

MediPharm Labs Reports Fourth Quarter and Full Year 2019 Results 2019 Revenue $129 Million, Adjusted EBITDA1 $25 Million Q4 2019 Revenue $32 Million, Adjusted EBITDA1 $3 Million Year-end Cash and Equivalents...
- March 30th, 2020 at 7:40 am